期刊文献+

IκB激酶-β抑制剂的研究与开发

Research and development of inhibitors of IκB kinase-β
下载PDF
导出
摘要 IκB激酶-β(IKK-β)与炎症和肿瘤的发生、发展密切相关。目前,IKK-β抑制剂的研究与开发已成为抗炎、抗肿瘤药物研究的一个新方向。近年来,相继报道了一些新型的合成或天然的IKK-β抑制剂,其中不乏一些高活性且具有药物开发前景的化合物。本文对新报道的IKK-β抑制剂进行了总结,并对这类结构化合物的开发做出展望。 IκB kinase-β(IKK-β) is associated with the development of inflammation and cancer,and it is a new target for curing inflammation and cancer. Among the reported new inhibitors, either synthetic or natural compounds that have high activity and are potentially valuable to explore are found. In this paper,novel IKK-β inhibitors and prospect of research on these compounds are summarized.
出处 《药学服务与研究》 CAS CSCD 2009年第1期22-27,共6页 Pharmaceutical Care and Research
基金 天津市科技支撑计划重点项目(No.07ZCKFSH00200)
关键词 IκB激酶-β 抑制剂 综述 抗炎 抗肿瘤 IκB kinase-β inhibitor review antiinflammation antineoplasm
  • 相关文献

参考文献21

  • 1Kim H J.HawkeN,Baldwin A S. NF-kB and tKK as therapeutic targets in cancer[J].Cell Death Differ, 2006,13(5): 738 -747.
  • 2Yamazaki S, Muta T, Takeshige K. A novel IkB protein, IkB-ξ, induced by proinflammtory stimuli, negatively regulates nuclear factor-kB in the nuclei[J]. J Biol Chem, 2001,276 (29):27657 -27662
  • 3Ghosh S, Karin M. Missing pieces in the NF-kB puzzle[J]. Cell, 2002,109 (Suppl) : S81-S96.
  • 4Baxter A, Brough S, Cooper A, et al. Hit-to-lead studies : the discovery of potent, orally active, thiophenecarboxamide IKK- 2 inhibitors[J].Bioorg Med Chem Lett,2004,14:2817-2822.
  • 5Podolin P L, Callahan J F, Bolognese B J,et al. Attenuation of murine collagen induced arthritis by a novel, potent, selective small molecule inhibitor of IkB kinase 2, TPCA-1 (2- [(aminocarbonyl) amino]-5-(4-fluorophenyl)-3 thiopbenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell proliferation[J]. J Pharmacol Exp Ther,2005,312(1):373-381.
  • 6Waelchli R, Bollbuck B, Bruns C, et al. Design and preparation of 2 benzamido-pyrimidines as inhibitors of IKK [J]. Bioorg Med Chem Lett,2006,16(1) : 108 -112.
  • 7BurkeJ R,Pattoli M A,Gregor K R,etal. BMS-345541 is a highly selective inhibitor of bob kinase that binds at an allos teric site of the enzyme and blocks NF-kB-dependent transcriptionin mice[J]. J Biochem,2003,278(3):1450 1456.
  • 8Beaulieu F,Ouellet C,Ruediger E H,etal. Synthesis and biological evaluation of 4 amino derivatives of benzimidazoquinoxaline, benzimidazoquinoline, and benzopyrazoloquinazoline as potent IKK inhibitors[J]. Bioorg Med Chem Lett,2007, 17:1233-1232.
  • 9Belema M, Bunker A, van Nguyen N, et al. Synthesis and structure activity relationship of imidazo ( 1,2 -α ) thieno ( 3, 2-e)pyrazines as IKK-β inhibitor[J]. Bioorg Med Chem Lett, 2007.17:4284-4289.
  • 10陈志东,皮尔·F·西里洛,达伦·迪萨尔沃.等.作为IKK抑制剂的被取代的3-氨基-噻吩并[2,3-B]吡啶2-羧酸酰胺化合物:中国,200480036200.7[P].2007-01-03.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部